Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-18 Purchase | 2024-12-18 6:01 pm | Rezolute Inc. | RZLT | Evans Daron CFO | 10,000 | $4.29 | $42,900 | 232,900 (Indirect Direct) | View |
| 2024-12-12 Purchase | 2024-12-12 4:54 pm | Rezolute Inc. | RZLT | Evans Daron CFO | 9,000 | $4.6 | $41,400 | 222,900 (Indirect Direct) | View |
| 2025-12-09 Purchase | 2024-12-10 09:11 am | Rezolute Inc. | RZLT | Evans Daron CFO | 10,549 | $5.04 | $53,167 | 213,900 (Indirect Direct) | View |
| 2024-06-14 Purchase | 2024-06-14 12:06 pm | Rezolute Inc. | RZLT | Evans Daron CFO | 40,000 | $4.0392 | $161,568 | 203,351 (Indirect Direct) | View |
| 2024-05-29 Purchase | 2024-05-31 4:05 pm | Rezolute Inc. | RZLT | Evans Daron CFO | 451 | $3.5 | $1,579 | 163,351 (Indirect Direct) | View |
| 2024-05-23 Purchase | 2024-05-28 2:48 pm | Rezolute Inc. | RZLT | Evans Daron CFO | 3,000 | $3.2227 | $9,668 | 162,900 (Indirect Direct) | View |
| 2024-03-15 Purchase | 2024-03-19 09:17 am | Rezolute Inc. | RZLT | Evans Daron CFO | 20,000 | $1.6915 | $33,830 | 159,900 (Indirect Direct) | View |
| 2024-03-08 Purchase | 2024-03-08 12:37 pm | Rezolute Inc. | RZLT | Evans Daron CFO | 50,000 | $1.9269 | $96,345 | 139,900 (Indirect Direct) | View |
| 2024-02-16 Purchase | 2024-02-20 07:01 am | Rezolute Inc. | RZLT | Evans Daron CFO | 50,900 | $1.3112 | $66,741 | 85,400 (Indirect Direct) | View |
| 2020-03-12 Purchase | 2020-03-12 5:02 pm | NEPHROS INC | NEPH | Evans Daron President and CEO | 2,500 | $6.65 | $16,625 | 533,756 (Indirect Direct) | View |
| 2020-03-05 Purchase | 2020-03-05 5:18 pm | NEPHROS INC | NEPH | Evans Daron President and CEO | 2,500 | $8.4436 | $21,109 | 531,256 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-23 Option Award | 2024-09-24 1:03 pm | N/A 2034-09-23 | Rezolute Inc. | RZLT | Evans Daron CFO | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 12:47 pm | N/A 2029-01-23 | Rezolute Inc. | RZLT | Evans Daron CFO | 275,000 | $0 | 275,000 (Direct) | View |
Ownership | 2024-01-25 12:46 pm | N/A N/A | Rezolute Inc. | RZLT | Evans Daron CFO | 0 | $0 | 39,000 (Direct) | View |
| 2021-05-27 Tax Withholding(A) | 2021-06-01 5:39 pm | N/A N/A | NEPHROS INC | NEPH | Evans Daron CEO Specialty Renal Products | 349 | $2.7 | 8,669 (Indirect) | View |
| 2021-05-24 Exercise | 2021-05-25 3:40 pm | 2016-06-03 2021-06-03 | NEPHROS INC | NEPH | Evans Daron CEO of Specialty Renal Product | 2,222 | $0 | 524,458 (Indirect) | View |
| 2021-05-24 Exercise | 2021-05-25 3:40 pm | N/A N/A | NEPHROS INC | NEPH | Evans Daron CEO of Specialty Renal Product | 1,111 | $2.7 | 524,458 (Indirect) | View |
| 2020-02-01 Option Award | 2020-02-05 5:13 pm | N/A 2025-04-15 | NEPHROS INC | NEPH | Evans Daron President and CEO | 97,076 | $0 | 528,756 (Direct) | View |